Skip to content New The AI buying guide for BD&L executives — now available on demand Watch
AI platform for biopharma AICPA SOC for Service Organizations logo SOC 2® Type 2

Search, evaluate, and prioritize promising therapeutics

VibeOne is the AI platform for biopharma BD, R&D and strategy teams, enabling faster, evidence-based decisions you can defend.
Your proprietary information is never exposed or used to train AI models
As seen in
The problem

Today’s BD process is slow, fragmented and hard to scale.

Problem 01

It's slow

Each analysis, landscape or diligence takes weeks or months of manual work. The answer can be out of date before a decision is made.
Problem 02

It's fragmented

Data is spread across databases, languages and VDRs. Teams check many sources and risk missing insights.
Problem 03

It doesn't scale

Each review depends on scarce, costly experts and consultants. Lean BD teams are asked to do more with the team they have.
Problem 04

General AI isn't enough

Conventional LLMs miss relevant information, hallucinate and exploit your proprietary data.
Why VibeOne

Answer BD questions faster, bring all your data together and scale with the team you already have.

Answers in minutes, not months

Each BD question is answered in minutes, and the analysis can be re-run whenever priorities shift.

Insights from each function, in one place

Glean insights across key disciplines, from biology to clinical development, sourced from databases, VDRs and 40+ languages. Every finding links to its source.

Scale without extra resources

Evaluate all opportunities across therapeutic areas quickly, using your own customized criteria. Reduce delays and dependence on consultants or experts at scale.

VibeOne results
18x
Faster indication analysis for a pharma client: 10 days vs. 6 months
50%+
More assets found in global landscapes, across 40+ languages
75%
Less expert time needed to reach a trusted due diligence result
4.6×
More assets found in a competitive landscape than a general AI tool
This was a game changer. VibeOne got done in 10 days, what would have taken 6 months. Now we are building drug programs in disease areas that we had never heard of until we used VibeOne.
The outcome
Two new drug programs started in diseases VibeOne surfaced, and the collaboration is expanding.
Who said it
Smitha Jagdish, PhD, VP, Rare Disease and New Modalities, Bial
Built for your role

See what VibeOne does for you

Compared

VibeOne against the alternatives

Scale without sacrificing rigor.

VibeOne

Global, consistent, source-traceable analysis at AI scale

Manual

Customized, but slow and unscalable

Consulting

Expensive, with limited context switching

General AI

Easy, but unreliable
Trust & security

Enterprise-grade security, independently examined under SOC 2® Type 2

Find your next asset with confidence.

See the evidence, the gaps, and how it compares.